ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Cidara Touts Positive Phase II Antifungal Data
biospace
March 20, 2018Shares of?Cidara Therapeutics?have fallen more than 22 percent this morning despite the company reporting its mid-stage antifungal candidate hit its primary endpoints and is on track to begin Phase III testing later this year.
Pharma Sources Insight January 2025
